- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
is a division of
Biotech Patents
Summary
15 Sep 2008-16 Sep 2008 — Boston, MA, United States
The ACI Biotech Patent Conference is the ONE place biotech patent practitioners come to learn and discuss the most recent and vital changes facing the industry today. You cannot afford to miss this essential briefing on the state of biotech patenting as it reels from not only new scientific advances, but also legislative and practical changes in the rules of patent practice.
Contact details
email: wougene@aci-ny.com phone: +1 888 224 2480
Venue
Royal Sonesta Hotel, Boston, MA, United States
— 15 Sep Mon-13:00 16 Sep 2008
The ACI Biotech Patent Conference is the ONE place biotech patent practitioners come to learn and discuss the most recent and vital changes facing the industry today. You cannot afford to miss this essential briefing on the state of biotech patenting as it reels from not only new scientific advances, but also legislative and practical changes in the rules of patent practice. It seems at every turn, patent practice is being assailed, whether through internal rule changes from the USPTO, profound federal court cases, public opinion demanding access to biosimilars, or overhauling legislation designed to pull the rug out from under traditional patent practice. The Biotech Patent community almost uniformly decries these changes as a potential for disaster.
Patents derived from biotechnology advancements are by nature profoundly unique, demanding an intense and time consuming scrutiny and review that other fields do not face. As a result of developments in the patent world as a whole, the majority of biotechnology companies and their patent agents and attorneys have been in a holding pattern of sorts for the past year, trying to position themselves and their clients in the best possible situation for whatever blows the industry takes. But as they face such uncertainty about both existing US biotech patents and the future nature of acquiring and protecting biotech patents, scientific advancements around the globe continue to move at hyperspeed. Keeping on top of all of these changes while still advancing the next stage of products from biotechnology has never been more crucial.
It is essential that you be prepared for the inevitable adaptations to your practice. Specifically, our expert faculty will answer the questions the industry demands, including:
- How will the decision in Tafas v. Dudas impact patent practices and what you can expect in the future?
- KSR, In re Kubin, In re Medimmune, In re Duel and other crucial cases: how these court decisions are being interpreted and applied by the USPTO and the Board of Patent Appeals and Interference
- The status of Follow-On Biologics: the European Patent Office has already taken steps to introduce them into the marketplace.With growing demand for generic products in the US, can the FDA and USPTO be far behind?
- As the USPTO continues to implement international patenting approval programs in conjunction with other nations, how do you implement global patent goals and standards into your patent practice?
- The essential skills needed to develop and prosecute an effective patent while avoiding questions of inequitable conduct, overbroad patents, and more.
This is a crucial time for biotech patents, and it is essential that you be ready to deal with the inevitable adjustments to the practice. As such, American Conference Institute has specifically designed its 10th Advanced Forum on Biotech Patents to provide you with a sophisticated and comprehensive understanding of the issues you face today. In addition, our esteemed faculty will guide you to the most effective practices you need to ensure protection of your biotech discovery.
As an added benefit, we offer our interactive and in-depth Master Class on Drafting and Successful Patent Applications for Biotechnology Related Inventions. Our expert faculty has designed the program to maximize the effectiveness of your biotech patent application. Their skills and knowledge of the unique challenges facing a biotech patent application are invaluable and will certainly shed light on techniques and procedures you should include when developing a patent application.
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us